Dr Melissa Heightman: key facts
- Kind of voice
- Clinician
- Role
- clinical lead for the post-Covid service at University College Hospital London
- Quoted on
- Long Covid, Respiratory (asthma/COPD)
- Tracked press citations
- 2
- Most recently quoted
- 30 Sept 2026
- First quoted
- 10 Sept 2026
“The referral trend is real, but it is likely due to people not testing for COVID”
What Dr Melissa Heightman has said
“It is heartening that people had a significant reduction in fatigue across all arms of the trial. This is more than you would expect based on time alone, given that participants had severe fatigue at recruitment and been ill for more than a year on average.”
clinical lead for the post-Covid service at University College Hospital London · Respiratory (asthma/COPD) · 10 Sept 2026 · Commonly-used drugs show small benefit for long-Covid fatigue ↗
Where Dr Melissa Heightman has been quoted
- England Closes Several Long-COVID Clinics, Deserting Patientsthinkglobalhealth.org · 30 Sept 2026
- Commonly-used drugs show small benefit for long-Covid fatiguepulsetoday.co.uk · 10 Sept 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.